More on ADIL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (2/17/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Adial Pharmaceuticals (NQ:ADIL)
Delayed: 1.83 -0.14 (7.11%)
Prev. Close $1.97  
Open$1.97 
52 Wk High$ 
52 Wk Low$ 
Day High$1.97 
Day Low$1.77 
P/E N/A  
EPS$ 
Volume99,158 

Friends, Peers and Foes (?): TMO (more...)

Mar 6, 2026 08:15 AM Form 8-K ADIAL PHARMACEUTICALS, For: Mar 06
Mar 6, 2026 08:00 AM Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
Mar 5, 2026 05:04 PM Form 10-K ADIAL PHARMACEUTICALS, For: Dec 31
Mar 3, 2026 08:17 AM Form 8-K ADIAL PHARMACEUTICALS, For: Feb 26
Mar 3, 2026 08:17 AM Adial Pharmaceuticals signs european deal worth up to $60 million
Mar 3, 2026 08:17 AM Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of
Feb 24, 2026 09:06 AM Form 8-K ADIAL PHARMACEUTICALS, For: Feb 23
Feb 24, 2026 09:00 AM Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement
Feb 23, 2026 08:31 AM Adial Pharmaceuticals notes FDA policy shift on trial requirements
Feb 23, 2026 08:30 AM Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
View All Articles

Entities mentioned with ADIL

View All Entities